Discovery of novel dual-target CDK12/PARP1 inhibitors for the treatment of triple-negative breast cancer.
- DOI
- 10.1016/j.ejmech.2026.119255
- Published
- 2026 Aug 20
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2026.119255,
title = {Discovery of novel dual-target CDK12/PARP1 inhibitors for the treatment of triple-negative breast cancer.},
author = {Zhong ZJ and Sun M and Luo ZW and Zhao XX and Lu C and He YQ and Wang LH and Zheng YJ and Lei J and Wang L and Zhang Z and Chen TG},
year = {2026},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2026.119255},
url = {https://doi.org/10.1016/j.ejmech.2026.119255}
}RIS
TY - JOUR TI - Discovery of novel dual-target CDK12/PARP1 inhibitors for the treatment of triple-negative breast cancer. AU - Zhong ZJ AU - Sun M AU - Luo ZW AU - Zhao XX AU - Lu C AU - He YQ AU - Wang LH AU - Zheng YJ AU - Lei J AU - Wang L AU - Zhang Z AU - Chen TG PY - 2026 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2026.119255 UR - https://doi.org/10.1016/j.ejmech.2026.119255 ER -
APA
ZJ, Z., M, S., ZW, L., XX, Z., C, L., YQ, H., LH, W., YJ, Z., J, L., L, W., Z, Z., & TG, C. (2026). Discovery of novel dual-target CDK12/PARP1 inhibitors for the treatment of triple-negative breast cancer.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.119255
Source records
- pubmed · retrieved 2026-09-26T06:25:01.972Z